Outset Medical Ownership | Who Owns Outset Medical?
Outset Medical Ownership Summary
Outset Medical is owned by 105.23% institutional investors, 2.68% insiders. Pfm health sciences, lp is the largest institutional shareholder, holding 9.38% of OM shares. Fidelity Select Health Care is the top mutual fund, with 7.53% of its assets in Outset Medical shares.
OM Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Outset Medical | 105.23% | 2.68% | -7.91% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Medical Device Stocks | 52.08% | 10.61% | 37.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Pfm health sciences, lp | 1.66M | 9.38% | $31.98M |
Durable capital partners lp | 1.66M | 9.34% | $31.83M |
T. rowe price investment management | 1.62M | 9.15% | $31.19M |
Alyeska investment group | 1.46M | 8.25% | $28.13M |
Morgan stanley | 3.82M | 7.50% | $14.69M |
Blackrock funding, inc. /de | 983.89K | 5.55% | $18.90M |
Perceptive advisors | 833.33K | 4.70% | $16.01M |
Massachusetts financial services co /ma/ | 636.33K | 3.59% | $12.22M |
Parkman healthcare partners | 549.05K | 3.09% | $10.55M |
Marshall wace, llp | 521.40K | 2.94% | $10.02M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Pura vida investments | 429.12K | 8.18% | $1.36M |
Pfm health sciences, lp | 1.66M | 2.75% | $31.98M |
Parkman healthcare partners | 549.05K | 1.21% | $10.55M |
Perceptive advisors | 833.33K | 0.59% | $16.01M |
Durable capital partners lp | 1.66M | 0.24% | $31.83M |
Birchview capital, lp | 24.58K | 0.24% | $271.90K |
Alyeska investment group | 1.46M | 0.10% | $28.13M |
Gmt capital | 98.11K | 0.08% | $1.88M |
Ctc alternative strategies | 24.47K | 0.04% | $94.22K |
T. rowe price investment management | 1.62M | 0.02% | $31.19M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock funding, inc. /de | 983.89K | 0.00% | 917.97K |
Renaissance | 686.75K | 0.00% | 632.57K |
Norges bank | 461.40K | 0.00% | 461.40K |
Pura vida investments | 429.12K | 8.18% | 424.12K |
Parkman healthcare partners | 549.05K | 1.21% | 317.95K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Fmr | - | - | -3.67M |
Vanguard group | - | - | -2.61M |
Blackrock | 880.46K | 0.00% | -2.39M |
Ameriprise financial | - | - | -1.81M |
Mubadala investment co pjsc | - | - | -1.44M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 461.40K | 0.00% | 461.40K | $1.78M |
Balyasny asset management | 143.16K | 0.00% | 143.16K | $2.75M |
Walleye capital | 56.10K | 0.00% | 56.10K | $1.08M |
Susquehanna portfolio strategies | 29.45K | 0.01% | 29.45K | $565.81K |
Ctc alternative strategies | 24.47K | 0.04% | 24.47K | $94.22K |
Sold Out
Holder | Change |
---|---|
Td waterhouse canada | -3.00 |
Ronald blue trust | -4.00 |
Cranbrook wealth management | -6.00 |
Wells fargo & company/mn | -11.00 |
First command advisory services | -12.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 92 | 41.54% | 18,671,271 | 27.00% | 105 | 13.14% | 63 | 215.00% | 14 | -66.67% |
Mar 31, 2025 | 1 | -98.72% | 24,584 | -99.88% | - | 0.00% | - | -100.00% | 1 | -95.83% |
Dec 31, 2024 | 31 | -62.20% | 7,241,955 | -72.21% | 14 | 0.54% | 11 | -54.17% | 9 | -74.29% |
Sep 30, 2024 | 81 | -33.06% | 26,057,063 | -46.36% | 51 | 0.57% | 25 | -59.68% | 35 | -7.89% |
Jun 30, 2024 | 121 | 6.14% | 48,575,467 | -2.94% | 95 | 0.96% | 62 | 31.91% | 38 | -5.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Select Health Care | 1.33M | 7.53% | - |
Fidelity Advisor Health Care I | 750.00K | 4.23% | -50.00K |
T. Rowe Price Small-Cap Stock | 719.35K | 4.06% | - |
T. Rowe Price US Small-Cap Core Equity | 719.35K | 4.06% | - |
Vanguard Total Stock Mkt Idx Inv | 554.44K | 3.12% | -12.22K |
MEDICAL BioHealth EUR Acc | 1.54M | 2.95% | 1.54M |
MFS New Discovery I | 430.59K | 2.42% | - |
iShares Russell 2000 ETF | 412.89K | 2.32% | -7.88K |
T. Rowe Price Instl Small-Cap Stock | 382.05K | 2.16% | - |
Fidelity Growth Compy Commingled Pl O | 1.05M | 2.01% | -769.40K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 15, 2025 | Trigg Leslie | Chair and CEO | Sell | $11.64K |
Aug 15, 2025 | Nash Marc | SVP Operations and R&D | Sell | $3.13K |
Aug 15, 2025 | Brottem John L. | General Counsel | Sell | $4.93K |
May 15, 2025 | Trigg Leslie | Chair and CEO | Sell | $16.64K |
May 15, 2025 | Nash Marc | SVP Operations and R&D | Sell | $4.49K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | 3 |
2025 Q2 | - | 4 |
2025 Q1 | - | 25 |
2024 Q4 | - | 4 |
2024 Q3 | - | 5 |
OM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools